Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination
Table 2
Screening for autoantibodies known to be associated to polymyositis, dermatomyositis, and isolated statin (HMG-CoA reductase inhibitor) causing myalgia.
Antibodies
Results
P-Glycyl-tRNA synthetase-Ab. (IgG)
Negative
P-Jo 1-antibody (IgG)
Negative
P-Histidine-tRNA-ligase (Jo1)-Ab. (IgG)
Negative
P-Isoleucyl-tRNA synth. cytop.-Ab. (IgG)
Negative
P-MDA5-antibody (IgG)
Negative
P-Mi-2a-antibody (IgG)
Negative
P-NXP2-antibody (IgG)
Negative
P-Polymyositis (Ku)-A (IgG)
Negative
P-Polymyositis (PL-12)-antibody
Negative
P-Polymyositis (PL-7)-Ab. (IgG)
Negative
P-Polymyositis (SRP)-Ab. (IgG)
Negative
P-SAE1-antibody (IgG)
Negative
P-TIF1 y-antibody (IgG)
Negative
HMG-CoA reductase-Ab. (IgG) (HMGCR), normal reference < 20
